medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Number 5

<< Back Next >>

Rev Invest Clin 2016; 68 (5)

Acute Respiratory Distress Syndrome Secondary to Influenza A(H1N1)pdm09: Clinical Characteristics and Mortality Predictors

Hernández-Cárdenas C, Serna-Secundino H, García-Olazarán JG, Aguilar-Pérez CL, Rocha-Machado J, Campos-Calderón LG, Lugo-Goytia G

Language: English
References: 35
Page: 235-244
PDF size: 135.30 Kb.


ABSTRACT

Background: Acute respiratory distress syndrome secondary to influenza A(H1N1)pdm09 virus is the leading cause of death among this patient population. Expanding the knowledge of its course and predictors of mortality is relevant to decision making. We aimed to describe the clinical characteristics and identify factors associated with mortality in patients with acute respiratory distress syndrome secondary to influenza A(H1N1)pdm09 during the 2013-2014 influenza season. Methods: This is an observational study of a prospective cohort of 70 patients with acute respiratory distress syndrome and influenza A(H1N1) pdm09 seen in an academic medical center. Multivariate logistic regression was used to identify the independent mortality predictors. Bootstrap was used for internal model validation. Results: This cohort was represented by young adults (43 ± 11 years old). Obesity was present in 62.5% and was not associated with mortality. Mortality at 28 days and at discharge from the respiratory intensive care unit was 14 and 20%, respectively. All patients met the criteria for acute respiratory distress syndrome, 73% had vasodilatory shock, and 27.1% had acute kidney injury on respiratory intensive care unit admission. We observed a high incidence of intensive care unit-acquired weakness (81.4%). Ventilator-associated pneumonia developed in 47.1% and was not associated with mortality. In multivariate analysis, independent risk factors for intensive care unit mortality were age (odds ratio [OR] = 1.102), white blood cell count (OR = 1.22), and lactate dehydrogenase levels (OR = 1.004) on admission to the intensive care unit. Conclusions: We described the clinical characteristics and course of a cohort of patients with acute respiratory distress syndrome secondary to influenza A(H1N1)pdm09, and developed a predictive model of mortality based on the covariates age, levels of lactate dehydrogenase, and white cell count on admission to the respiratory intensive care unit.


REFERENCES

  1. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680-9.

  2. Domínguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA. 2009;302:1880-7.

  3. Kumar A, Zarychanski R, Pinto R, et al.; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA. 2009;302: 1872-9.

  4. Rello J, Rodríguez A, Ibañez P, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13:R148.

  5. Borja-Aburto VH, Chowell G, Viboud C. Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. Arch Med Res. 2012;43:563-70.

  6. Dávila-Torres J, Chowell G, Borja-Aburto VH, Viboud C, Grajalez- Muñiz C, Miller MA. Intense seasonal A/H1N1 influenza in Mexico, winter 2013-2014. Arch Med Res. 2015;46:63-70.

  7. E lnifro EM, Ashshi AM, Cooper RJ, Klapper PE. Multiplex PCR: Optimization and application in diagnostic virology. Clin Microb Rev. 2000;13:559-70.

  8. Vincent JL, Moreno R, Takala J, Willats S. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med. 1996;22:707-10.

  9. A RDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-33.

  10. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.

  11. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.

  12. World Health Organization. WHO guidelines for pharmacologic management of pandemic (H1N1) 2009 influenza and other influenza viruses. Geneva (Switzerland): The Organization; 2009.

  13. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14: 1103-9.

  14. Rodríguez A, Díaz E, Martín-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011;66: 1140-9.

  15. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395-404.

  16. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis. 2007;195:1018-28.

  17. Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic Influenza A (H1N1) virus and bacterial co-infection in the United States. Crit Care Med. 2012;40:1487-98.

  18. Miller III RR, Markewitz BA, Rolfs RT, et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest. 2010;137:752-8.

  19. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009;13:R201.

  20. Hayden FC, Fritz RS, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human Influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998;101:643-9.

  21. G ao R, Bhatnagar J, Blau DM. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1). Role of the host immune response in pathogenesis. Am J Pathol. 2013;183:1258-68.

  22. Pfister R, Kochanek M, Leygeber T, et al. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Crit Care. 2014;18:R44.

  23. World Health Organization. Obesity (body mass index >= 30) (age-standardized estimate) Data by country. Available at: http://apps.who.int/gho/data/node.main.A900A?lang=en

  24. Ribeiro AF, Pellini AC, Kitagawa BY, et al. Risk factors for death from influenza A (H1N1)pdm09, State of São Paulo, Brazil, 2009. PLoS One. 2015;10:e0118772.

  25. Fezeu L, Julia C, Henegar A. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev. 2011;12:653-9.

  26. Díaz E, Rodríguez A, Martin-Loeches I, et al. Impact of obesity in patients infected with 2009 Influenza A(H1N1). Chest. 2011; 139:382-6.

  27. Smith RL, Ripps CS, Lewis ML. Elevated lactate dehydrogenase values in patients with Pneumocystis carinii pneumonia. Chest. 1998;93:967-92.

  28. T sui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcomes and prognostic correlates. Emerg Infect Dis. 2003;9:1064-9.

  29. Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139:715-23.

  30. Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev. 2008;21:473-94.

  31. A yala E, Kagawa FT, Whener JH, Tam J. Rhabdomyolysis associated with 2009 influenza A (H1N1). JAMA. 2009;302:1863-4.

  32. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708-19.

  33. Desdouits M, Munier S, Prevost MC, et al. Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses. PLoS One. 2013;8:e79628.

  34. Bagshaw SM, Sood MM, Long J, Fowler RA, Adhikari NKJ; Canadian Critical Care Trials Group H1N1 Collaborative. Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study. BMC Nephrol. 2013;14:123.

  35. Martin-Loeches I, Papiol E, Rodríguez A, et al.; H1N1 SEMICYUC Working Group. Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection. Crit Care. 2011; 15:R66.




2020     |     www.medigraphic.com